Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies

Cristina Nanni, Cinzia Pettinato, Valentina Ambrosini, Antonello Spinelli, Silvia Trespidi, Domenico Rubello, Adil Al-Nahhas, Roberto Franchi, Abass Alavi, Stefano Fanti

Research output: Contribution to journalArticle

Abstract

BACKGROUND AND AIM: Small-animal PET is acquiring importance for pre-clinical studies. In rodents, radiotracers are usually administrated via the tail vein. This procedure can be very difficult and time-consuming as soft tissue extravasations are very frequent and tail scars can prevent repeated injections after initial failure. The aim of our study was to compare the retro-orbital (RO) versus tail vein intravenous (i.v.) administration of F-FDG and C-choline in mice for small-animal PET studies. METHODS: We evaluated four healthy female ICR CD1 mice according to the following protocol. Day 1: each animal underwent an i.v. injection of 28 MBq of C-choline. PET scan was performed after 10 min and 40 min. Day 2: each animal received an RO injection of 28 MBq of C-choline. A PET scan was performed after 10 min and 40 min. Day 3: each animal received an i.v. injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Day 4: each animal received an RO injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Administration and image acquisition were performed under gas anaesthesia. For FDG studies the animals fasted for 2 h and were kept asleep for 20-30 min after injection, to avoid muscular uptake. Images were reconstructed with 2-D OSEM. For each scan ROIs were drawn on liver, kidneys, lung, brain, heart brown fat and muscles, and the SUV was calculated. We finally compared choline i.v. standard acquisition to choline RO standard acquisition; choline i.v. delayed acquisition to choline RO delayed acquisition; FDG i.v. standard acquisition to FDG RO standard acquisition; FDG i.v. delayed acquisition to FDG RO delayed acquisition. RESULTS: The RO injections for both F-FDG and C-choline were comparable to the intravenous injection of F-FDG for the standard and delayed acquisitions. CONCLUSION: The RO administration in mice represents a technical advantage over intravenous administration in being an easier and faster procedure. However, its use requires high specific activity while its value in peptides and other receptor-specific radiopharmaceuticals needs further assessment.

Original languageEnglish
Pages (from-to)547-553
Number of pages7
JournalNuclear Medicine Communications
Volume28
Issue number7
DOIs
Publication statusPublished - Jul 2007

Fingerprint

Radiopharmaceuticals
Choline
Injections
Positron-Emission Tomography
Intravenous Injections
Tail
Intravenous Administration
Veins
Inbred ICR Mouse
Brown Adipose Tissue
Peptide Receptors
Needs Assessment
Cicatrix
Rodentia
Anesthesia
Gases
Kidney
Muscles
Lung
Liver

Keywords

  • C-choline
  • F-FDG
  • Retro-orbital injection
  • Route of administration
  • Small-animal PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. / Nanni, Cristina; Pettinato, Cinzia; Ambrosini, Valentina; Spinelli, Antonello; Trespidi, Silvia; Rubello, Domenico; Al-Nahhas, Adil; Franchi, Roberto; Alavi, Abass; Fanti, Stefano.

In: Nuclear Medicine Communications, Vol. 28, No. 7, 07.2007, p. 547-553.

Research output: Contribution to journalArticle

Nanni, C, Pettinato, C, Ambrosini, V, Spinelli, A, Trespidi, S, Rubello, D, Al-Nahhas, A, Franchi, R, Alavi, A & Fanti, S 2007, 'Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies', Nuclear Medicine Communications, vol. 28, no. 7, pp. 547-553. https://doi.org/10.1097/MNM.0b013e3281fbd42b
Nanni, Cristina ; Pettinato, Cinzia ; Ambrosini, Valentina ; Spinelli, Antonello ; Trespidi, Silvia ; Rubello, Domenico ; Al-Nahhas, Adil ; Franchi, Roberto ; Alavi, Abass ; Fanti, Stefano. / Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. In: Nuclear Medicine Communications. 2007 ; Vol. 28, No. 7. pp. 547-553.
@article{203936fc257d438183f7b94e8fdcf115,
title = "Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies",
abstract = "BACKGROUND AND AIM: Small-animal PET is acquiring importance for pre-clinical studies. In rodents, radiotracers are usually administrated via the tail vein. This procedure can be very difficult and time-consuming as soft tissue extravasations are very frequent and tail scars can prevent repeated injections after initial failure. The aim of our study was to compare the retro-orbital (RO) versus tail vein intravenous (i.v.) administration of F-FDG and C-choline in mice for small-animal PET studies. METHODS: We evaluated four healthy female ICR CD1 mice according to the following protocol. Day 1: each animal underwent an i.v. injection of 28 MBq of C-choline. PET scan was performed after 10 min and 40 min. Day 2: each animal received an RO injection of 28 MBq of C-choline. A PET scan was performed after 10 min and 40 min. Day 3: each animal received an i.v. injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Day 4: each animal received an RO injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Administration and image acquisition were performed under gas anaesthesia. For FDG studies the animals fasted for 2 h and were kept asleep for 20-30 min after injection, to avoid muscular uptake. Images were reconstructed with 2-D OSEM. For each scan ROIs were drawn on liver, kidneys, lung, brain, heart brown fat and muscles, and the SUV was calculated. We finally compared choline i.v. standard acquisition to choline RO standard acquisition; choline i.v. delayed acquisition to choline RO delayed acquisition; FDG i.v. standard acquisition to FDG RO standard acquisition; FDG i.v. delayed acquisition to FDG RO delayed acquisition. RESULTS: The RO injections for both F-FDG and C-choline were comparable to the intravenous injection of F-FDG for the standard and delayed acquisitions. CONCLUSION: The RO administration in mice represents a technical advantage over intravenous administration in being an easier and faster procedure. However, its use requires high specific activity while its value in peptides and other receptor-specific radiopharmaceuticals needs further assessment.",
keywords = "C-choline, F-FDG, Retro-orbital injection, Route of administration, Small-animal PET",
author = "Cristina Nanni and Cinzia Pettinato and Valentina Ambrosini and Antonello Spinelli and Silvia Trespidi and Domenico Rubello and Adil Al-Nahhas and Roberto Franchi and Abass Alavi and Stefano Fanti",
year = "2007",
month = "7",
doi = "10.1097/MNM.0b013e3281fbd42b",
language = "English",
volume = "28",
pages = "547--553",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies

AU - Nanni, Cristina

AU - Pettinato, Cinzia

AU - Ambrosini, Valentina

AU - Spinelli, Antonello

AU - Trespidi, Silvia

AU - Rubello, Domenico

AU - Al-Nahhas, Adil

AU - Franchi, Roberto

AU - Alavi, Abass

AU - Fanti, Stefano

PY - 2007/7

Y1 - 2007/7

N2 - BACKGROUND AND AIM: Small-animal PET is acquiring importance for pre-clinical studies. In rodents, radiotracers are usually administrated via the tail vein. This procedure can be very difficult and time-consuming as soft tissue extravasations are very frequent and tail scars can prevent repeated injections after initial failure. The aim of our study was to compare the retro-orbital (RO) versus tail vein intravenous (i.v.) administration of F-FDG and C-choline in mice for small-animal PET studies. METHODS: We evaluated four healthy female ICR CD1 mice according to the following protocol. Day 1: each animal underwent an i.v. injection of 28 MBq of C-choline. PET scan was performed after 10 min and 40 min. Day 2: each animal received an RO injection of 28 MBq of C-choline. A PET scan was performed after 10 min and 40 min. Day 3: each animal received an i.v. injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Day 4: each animal received an RO injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Administration and image acquisition were performed under gas anaesthesia. For FDG studies the animals fasted for 2 h and were kept asleep for 20-30 min after injection, to avoid muscular uptake. Images were reconstructed with 2-D OSEM. For each scan ROIs were drawn on liver, kidneys, lung, brain, heart brown fat and muscles, and the SUV was calculated. We finally compared choline i.v. standard acquisition to choline RO standard acquisition; choline i.v. delayed acquisition to choline RO delayed acquisition; FDG i.v. standard acquisition to FDG RO standard acquisition; FDG i.v. delayed acquisition to FDG RO delayed acquisition. RESULTS: The RO injections for both F-FDG and C-choline were comparable to the intravenous injection of F-FDG for the standard and delayed acquisitions. CONCLUSION: The RO administration in mice represents a technical advantage over intravenous administration in being an easier and faster procedure. However, its use requires high specific activity while its value in peptides and other receptor-specific radiopharmaceuticals needs further assessment.

AB - BACKGROUND AND AIM: Small-animal PET is acquiring importance for pre-clinical studies. In rodents, radiotracers are usually administrated via the tail vein. This procedure can be very difficult and time-consuming as soft tissue extravasations are very frequent and tail scars can prevent repeated injections after initial failure. The aim of our study was to compare the retro-orbital (RO) versus tail vein intravenous (i.v.) administration of F-FDG and C-choline in mice for small-animal PET studies. METHODS: We evaluated four healthy female ICR CD1 mice according to the following protocol. Day 1: each animal underwent an i.v. injection of 28 MBq of C-choline. PET scan was performed after 10 min and 40 min. Day 2: each animal received an RO injection of 28 MBq of C-choline. A PET scan was performed after 10 min and 40 min. Day 3: each animal received an i.v. injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Day 4: each animal received an RO injection of 28 MBq of F-FDG. A PET scan was performed after 60 min and 120 min. Administration and image acquisition were performed under gas anaesthesia. For FDG studies the animals fasted for 2 h and were kept asleep for 20-30 min after injection, to avoid muscular uptake. Images were reconstructed with 2-D OSEM. For each scan ROIs were drawn on liver, kidneys, lung, brain, heart brown fat and muscles, and the SUV was calculated. We finally compared choline i.v. standard acquisition to choline RO standard acquisition; choline i.v. delayed acquisition to choline RO delayed acquisition; FDG i.v. standard acquisition to FDG RO standard acquisition; FDG i.v. delayed acquisition to FDG RO delayed acquisition. RESULTS: The RO injections for both F-FDG and C-choline were comparable to the intravenous injection of F-FDG for the standard and delayed acquisitions. CONCLUSION: The RO administration in mice represents a technical advantage over intravenous administration in being an easier and faster procedure. However, its use requires high specific activity while its value in peptides and other receptor-specific radiopharmaceuticals needs further assessment.

KW - C-choline

KW - F-FDG

KW - Retro-orbital injection

KW - Route of administration

KW - Small-animal PET

UR - http://www.scopus.com/inward/record.url?scp=34249781398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249781398&partnerID=8YFLogxK

U2 - 10.1097/MNM.0b013e3281fbd42b

DO - 10.1097/MNM.0b013e3281fbd42b

M3 - Article

C2 - 17538396

AN - SCOPUS:34249781398

VL - 28

SP - 547

EP - 553

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 7

ER -